Amniotic fluid erythropoietin and neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks
- 5 December 2014
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 94 (3) , 288-294
Abstract
Objective: High amniotic fluid erythropoietin concentration reflects chronic fetal hypoxia. Our aim was to study amniotic fluid erythropoietin concentration in relation to neonatal outcome in pregnancies complicated by intrauterine growth restriction.Design: Retrospective case series.Setting: Helsinki University Hospital, Finland.Sample: A total of 66 singleton pregnancies complicated by intrauterine growth restriction.Methods: Amniocentesis or amniotic fluid sampling at cesarean section was performed between 24 and 34 gestational weeks. Values of amniotic fluid erythropoietin were quantitated with immunochemiluminometric assay. Normal amniotic fluid erythropoietin was defined as 27 IU/L.Main outcome measures: Adverse neonatal outcome.Results: Abnormal biophysical profile and reversed end‐diastolic flow in umbilical artery were associated with abnormal amniotic fluid erythropoietin (p < 0.001 and p = 0.042, respectively). Abnormal amniotic fluid erythropoietin was not associated with absent end‐diastolic flow in umbilical artery or with oligohydramnios (p = 0.404 and p = 0.080, respectively). Decreased umbilical artery pH and base excess values were associated with abnormal amniotic fluid erythropoietin (p = 0.027 and p = 0.007, respectively). Composite adverse neonatal outcome defined as intraventricular hemorrhage, periventricular leukomalacia, cerebral infarction and/or necrotizing enterocolitis was associated with abnormal amniotic fluid erythropoietin (p < 0.001).Conclusions: High amniotic fluid erythropoietin concentrations are associated with decreased umbilical artery pH and base excess and with adverse neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks. In selected pregnancies complicated by intrauterine growth restriction, determining amniotic fluid erythropoietin could be a useful additional tool in fetal surveillance and possibly in optimizing timing of delivery.Keywords
Funding Information
- Finska Läkaresällskapet
- Päivikki and Sakari Sohlberg foundation
- Special governmental subsidy for health sciences research for Helsinki University Hospital
- Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne
- the Foundation for Pediatric Research
This publication has 31 references indexed in Scilit:
- Fetal growth restriction: current knowledge to the general Obs/GynArchives of Gynecology and Obstetrics, 2012
- Timing Delivery of the Growth-Restricted FetusSeminars in Perinatology, 2011
- Increased Fetal Plasma and Amniotic Fluid Erythropoietin Concentrations: Markers of Intrauterine HypoxiaNeonatology, 2008
- Cerebral palsy and restricted growth status at birth: population‐based case–control studyBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertensionJournal of Perinatal Medicine, 2004
- Restricted fetal growth in sudden intrauterine unexplained deathActa Obstetricia et Gynecologica Scandinavica, 2004
- Fetal assessment based on fetal biophysical profile scoringAmerican Journal of Obstetrics and Gynecology, 1998
- Direct relationship of antepartum glucose control and fetal erythropoietin in human Type 1 (insulin-dependent) diabetic pregnancyDiabetologia, 1990
- Amniotic fluid erythropoietin predicts fetal distress in Rh-immunized pregnanciesAmerican Journal of Obstetrics and Gynecology, 1989
- ErythropoietinTransfusion, 1989